New York Risperdal Lawsuits Could Move Forward

New York Risperdal LawsuitAccording to a court order update on September 24, 2013, the first three bellwether trials in the Risperdal proceeding that is currently underway in the Philadelphia Court of Common Pleas has been rescheduled. The first trial has been moved back to November 3, 2014 from September 29, 2014; the second trial is scheduled to start on January 3, 2015 rather than November 3, 2014; and the third trial has yet to be scheduled, but it is expected to begin sometime in February 2015.

Attorney Group for New York is remaining up-to-date with the Risperdal litigation and offers free consultations to those who took Risperdal and developed gynecomastia, which is breast growth in males. Contact us today to learn more about your options if you believe you have a case.

Risperdal Lawsuits Filed Throughout the U.S.

Johnson & Johnson has been named as a defendant in more than 700 Risperdal gynecomastia lawsuits, according to court documents. Plaintiffs accuse the company of hiding the risks of Risperdal from physicians and consumers to protect the company’s sales, and claim that Risperdal is a defective drug that causes serious complications such as abnormal breast growth in young boys and men. As a result, plaintiffs are seeking compensation from the manufacturer to pay for lost wages, medical expenses for surgeries and treatments to remove the extra breast tissue, pain and suffering, and emotional trauma and embarrassment.

Risperdal May Cause Gynecomastia, Diabetes, Studies Show

Researchers have recently found that older men who take Risperdal and other atypical antipsychotic medications are 69 percent more likely to suffer from abnormal male breast growth than study participants who did not take Risperdal. The study, published on August 6, 2014 in the Journal of Clinical Psychopharmacology suggested that Risperdal and similar medications may increase the hormone prolactin in the body, which is responsible for lactation and breast development in females.

In August 2013 and September 2014, two separate studies found a link between Risperdal and another disease –type 2 diabetes. Researchers in both studies concluded that children who took the drug were three times more likely to develop the condition than children who were not administered the products.

Attorney Group for New York Can Help File Your Risperdal Lawsuit

If you or your child took Risperdal and suffered from abnormal breast growth, or gynecomastia, Attorney Group for New York is available for assistance. We provide free case evaluations to those who believe they may be entitled to recover damages for your injuries, and if we find that you have a case, we can connect you with an affiliated attorney in New York who can file your Risperdal lawsuit on your behalf.